| |
| |
| Oral |
| PROTOZOAL INFECTIONS E.G. MALARIA, BALANTIDIASIS, AMOEBIASIS |
| Adult:
6-9 million units/day in 2-3 divided doses, increased to 15 million units/day, given in divided doses for severe infections. |
| |
| Oral |
| PROTOZOAL INFECTIONS E.G. MALARIA, BALANTIDIASIS, AMOEBIASIS |
| Child:
and neonates: Chemoprophylaxis of congenital toxoplasmosis: 50 mg/kg bid. |
| |
| Oral |
| TOXOPLASMOSIS |
| Adult:
6-9 million units/day in 2-3 divided doses, increased to 15 million units/day, given in divided doses for severe infections. |
| |
| Oral |
| TOXOPLASMOSIS |
| Child:
and neonates: Chemoprophylaxis of congenital toxoplasmosis: 50 mg/kg bid. |
| |
| Oral |
| CRYPTOSPORIDIOSIS |
| Adult:
6-9 million units/day in 2-3 divided doses, increased to 15 million units/day, given in divided doses for severe infections. |
| |
| Oral |
| CRYPTOSPORIDIOSIS |
| Child:
and neonates: Chemoprophylaxis of congenital toxoplasmosis: 50 mg/kg bid. |
| |
| Oral |
| SUSCEPTIBLE INFECTIONS |
| Adult:
6-9 million units/day in 2-3 divided doses, increased to 15 million units/day, given in divided doses for severe infections. |
| |
| Oral |
| SUSCEPTIBLE INFECTIONS |
| Child:
and neonates: Chemoprophylaxis of congenital toxoplasmosis: 50 mg/kg bid. |
| |
| Intravenous |
| TOXOPLASMOSIS |
| Adult:
1.5 million units by slow infusion every 8 hr, may double the dose in severe infections. |
| |
| Intravenous |
| CRYPTOSPORIDIOSIS |
| Adult:
1.5 million units by slow infusion every 8 hr, may double the dose in severe infections. |
| |
| Intravenous |
| PROTOZOAL INFECTIONS E.G. MALARIA, BALANTIDIASIS, AMOEBIASIS |
| Adult:
1.5 million units by slow infusion every 8 hr, may double the dose in severe infections. |
| |
| Intravenous |
| SUSCEPTIBLE INFECTIONS |
| Adult:
1.5 million units by slow infusion every 8 hr, may double the dose in severe infections. |
